Key Findings
The Europe market for PCTA balloon catheters is driven by the increased incidences of stroke, heart attacks, and other cardiac diseases. The high prevalence of stroke among Europeans has prompted a rise in the use of balloon catheters for the treatment of the diseases. The estimated growth of the said market in Europe is predicted to be 4.53% CAGR during the forecasting years of 2019-2027.

Market Insights
The economies of Germany, France, the United Kingdom, Italy and the Rest of Europe will influential for the market growth. The opportunities for the growth of the PTCA balloon catheters market is growing at the highest rate in Europe. The surge in death rates in some of the countries owing to increase in cardiac disorders had led to increased usage of balloon catheters for the treatment of narrowed arteries.

Intensification in the geriatric population and changes in the lifestyle of people, technological advancements, an increase in the prevalence of cardiovascular disorders, etc. are expected to increase the implementation of PCTA balloon catheters.

Competitive Insights
The major companies that are contending in the Europe market are C. R. Bard, Inc., Medtronic PLC, Cordis, Microport Scientific Corporation, Cook Medical LLC, Spectranetics, Cardinal Health Inc., Abbott Laboratories, Endocor GmbH, Terumo Corporation, Biotronik Se & Co. KG, B Braun Melsungen AG, and Boston Scientific Corporation.